Man Faints in Oval Office During Obesity Drug Announcement
A White House press conference was interrupted on Thursday when a man fainted in the Oval Office. President Donald Trump was announcing a deal with drugmakers aimed at lowering the cost of obesity drugs when the incident occurred.
The video capturing the man collapsing quickly spread online. Independent journalist Eric Daugherty shared the footage, saying,
“A man just passed out during President Trump’s Oval Office announcement. Oz SPRUNG into action and assisted him.”
“Pray for him.”
Many viewers offered prayers for the man's well-being as the live feed was cut short. The man was originally identified as Gordon Findlay, and some claimed he was a Novo Nordisk executive. One account on X posted:
“BREAKING: Novo Nordisk executive Gordon Findlay collapses during Trump's announcement in Oval Office, announcement suspended.”
Company Clarifies Identity of the Man
However, Novo Nordisk clarified that the man was not affiliated with their company. A spokesperson told Newsweek:
“CEO Mike Doustdar and EVP, US Operations, Dave Moore were the only two Novo Nordisk representatives in the Oval Office. We hope the gentleman who suffered a medical incident today is okay.”
White House Statement
White House Press Secretary Karoline Leavitt provided additional information about the situation, stating,
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted.”
Summary
The man who fainted during the Oval Office announcement about obesity drugs was mistakenly identified as a Novo Nordisk executive, but the company confirmed this was not the case.
Author's note: The incident highlighted the sudden health emergency but also the importance of verifying information before sharing.
Would you like the tone to be more formal or conversational?